A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Hemorragia intracerebral (lobular); hemorragia intraparenquimal
El tratamiento y control de los trastornos causales y relacionados con el riesgo pueden disminuir la posibilidad de desarrollar hemorragia intracerebral.
La hipertensión arterial se debe tratar apropiadamente. No deje de tomar medicamentos que le hayan recetado, a menos que el médico lo aconseje. La suspensión repentina de éstos puede conducir a este trastorno.
Si toma anticoagulantes, como Coumadin, el médico puede ordenar exámenes de sangre regulares para constatar que la dosis del medicamento no esté aumentando el riesgo de sangrado.
Zivin JA. Hemorrhagic cerebrovascular disease. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 432.
Goldstein LB. Prevention and management of stroke. In: Libby P, Bonow RO, Mann DL, Zipes DP, eds. Libby: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Saunders;2007:chap 58.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885